Biclonal systemic AL-amyloidosis with one glycosylated and one nonglycosylated AL-protein

Scandinavian Journal of Immunology

Volumn 57, Issue 4, 2003, Pages 319-323

  Karimi, M ^a   Sletten, K ^a   Westermark, P ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMYLOID; AMYLOID PROTEIN; ANAZOLENE SODIUM; MONOSACCHARIDE; OLIGOSACCHARIDE; PEPTIDE DERIVATIVE; THREONINE;

AGED; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; ARTICLE; CARBOHYDRATE ANALYSIS; CASE REPORT; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MOLECULAR WEIGHT; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; SEQUENCE HOMOLOGY; SPLEEN; STAINING;

AGED; AMINO ACID SEQUENCE; AMYLOID; AMYLOIDOSIS; CHROMATOGRAPHY, GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; LIVER; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, PROTEIN; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 0037384068     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01230.x     Document Type: Article

References (13)

1. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol 1995;32:45-59.
2. Engvig JP, Olsen KE, Gislefoss RE, Sletten K, Wahlstrøm O, Westermark P. Constant region of a κIII immunoglobulin light chain as a major AL-amyloid protein. Scand J Immunol 1998;48:92-8.
3. Olsen KE, Sletten K, Westermark P. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins. Biochem Biophys Res Commun 1998;251:642-7.
4. Solomon A, Weiss DT, Murphy CL, Hrncic R, Wall JS, Schell M. Light chain-associated amyloid deposits comprised of a novel κ constant domain. Proc Natl Acad Sci USA 1998;95:9547-51.
5. Raffen R, Dieckman LJ, Szpunar M et al. Physiochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains. Protein Sci 1999;8:509-17.
6. Sletten K, Westermark P, Husby G. Structural studies of the variable region of immunoglobulin light-chain-chain-type amyloid fibril proteins. In: Glenner GG, Osserman EF, Benditt EP, Calkins E, Cohen AS, Zucker-Franklin D, eds. Amyloidosis. New York: Plenum Press, 1986, 463-75.
7. Omtvedt LAa, Bailey D, Renouf DV et al. Glycosylation of immunoglobulin light chains associated with amyloidosis. Amyloid 2000;7:227-44.
8. Stevens FJ. Four structural risk factors identify most fibril-forming kappa light chains. Amyloid 2000;7:200-11.
9. Samdal IA, Sletten K, Olsen KE, Westermark P. AL 366 - a glycosylated protein of kappa 1b origin in a patient with systemic amyloidosis of predominantly non-parenchymatous distribution. Amylold 2001;8:111-4.
10. Syversen PV, Juul J, Marhaug G, Husby G, Sletten K. The primary structure of serum amyloid A protein in the sheep: comparison with serum amyloid A in other species. Scand J Immunol 1994;39:88-94.
11. Laemmlie UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;277:680-5.
12. Carlsson RS. Analysis of glycoproteins by SDS-PAGE. In: Fukuda M, Kobata A, eds. Glycobiology: The Practical Approach Series. Oxford, UK: Oxford University Press, 1993, 1-26.
13. Comenzo RL, Zhang Y, Martinez C, Osman K, Herrera G. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden. Blood 2001;98:714-20.